Stockscreener 앱 받기
156.98
2.02%
3.11
시간 외 거래:
160.70
3.72
+2.37%
Krystal Biotech Inc 주식(KRYS)의 최신 뉴스
Local biotech co-founder named to Forbes 50 Over 50 - The Business Journals
KRYSTAL BIOTECH Earnings Preview: Recent $KRYS Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative
Earnings Outlook For Krystal Biotech - 富途牛牛
What makes Krystal Biotech Inc. stock price move sharplyTrend Reversal Signal Prediction Outlook - beatles.ru
What are analysts’ price targets for Krystal Biotech Inc. in the next 12 monthsDaily Trading Opportunities For Consistent Profits - jammulinksnews.com
How does Krystal Biotech Inc. compare to its industry peersEarnings Report Growth Plan For Smart Trading - jammulinksnews.com
Why is Krystal Biotech Inc. stock attracting strong analyst attentionAI Powered Growth Plan From AI Tools - jammulinksnews.com
Quantitative breakdown of Krystal Biotech Inc. recent moveAlpha Driven Watchlist With Alerts Published - metal.it
How Krystal Biotech Inc. stock performs during market volatilityTechnical Stock Breakout Predictions Signal Entry Points - metal.it
Why Krystal Biotech Inc. stock attracts strong analyst attentionWeekly Chart Analysis With Entry Advice Provided - metal.it
Why We're Not Concerned About Krystal Biotech, Inc.'s (NASDAQ:KRYS) Share Price - 富途牛牛
Krystal Biotech to Report Second Quarter 2025 Financial Results on August 4, 2025 - The Manila Times
Will Krystal Biotech Inc. Recover After Recent DeclineIntraday Trend Analysis for Fast Gains Released - metal.it
What is the risk reward ratio of investing in Krystal Biotech Inc. stockAdvanced Screener Guidance With High Returns - jammulinksnews.com
Krystal Biotech receives regulatory approval to expand to Japan - The Business Journals
Krystal Biotech, Inc. (KRYS) to Report Q2 Results: Wall Street Expects Earnings Growth - Yahoo Finance
Krystal Biotech’s Vyjuvek authorised in Japan to treat DEB - World Pharmaceutical Frontiers
What is the dividend policy of Krystal Biotech Inc. stockUnlock your portfolio’s hidden potential - jammulinksnews.com
How volatile is Krystal Biotech Inc. stock compared to the marketFree Stock Chart Pattern Guide - jammulinksnews.com
What catalysts could drive Krystal Biotech Inc. stock higher in 2025Post Market Outlook For Smart Trading - jammulinksnews.com
Is Krystal Biotech Inc. stock overvalued or undervaluedUnlock your portfolio’s full growth potential - jammulinksnews.com
Krystal Biotech Retains 'Buy' Rating with $219 Price Target - AInvest
Krystal Biotech’s Subsidiary Reports Positive Phase 1 Results - The Globe and Mail
A Quick Look at Today's Ratings for Krystal Biotech(KRYS.US), With a Forecast Between $192 to $240 - 富途牛牛
Krystal Biotech (KRYS) Retains 'Buy' Rating with $219 Price Targ - GuruFocus
What analysts say about Krystal Biotech Inc. stockSuperior returns - PrintWeekIndia
Positive Phase 1 Trial Results for KB304 Bolster Buy Rating for Krystal Biotech Amidst Promising Market Potential - TipRanks
Krystal Biotech Gains Approval for DEB Treatment in Japan - TipRanks
Krystal Biotech Announces Approval of VYJUVEK® by Japan’s Ministry of Health, Labour and Welfare for the Treatment of Dystrophic Epidermolysis Bullosa - The Manila Times
Krystal Biotech's VYJUVEK Receives Approval in Japan for Dystrophic Epidermolysis Bullosa Treatment from Birth - Quiver Quantitative
Is Krystal Biotech Inc. a good long term investmentFree Predictions - PrintWeekIndia
Revolutionary Genetic Treatment for Rare Skin Disease Gets Historic Japan Approval with Home Use Option - Stock Titan
What risks could impact Krystal Biotech Inc. stock performanceTremendous gains - jammulinksnews.com
Krystal Biotech’s Promising Aesthetic Developments and Positive Phase I Results Justify Buy Rating - TipRanks
What drives Krystal Biotech Inc. stock priceFree Wealth Management Insights - PrintWeekIndia
Jeune Announces Positive Results and Significant Aesthetic - GlobeNewswire
Analysts Offer Insights on Healthcare Companies: Krystal Biotech (KRYS), Abivax SA Sponsored ADR (ABVX) and Kyowa Kirin Co (OtherKYKOF) - The Globe and Mail
Phase 1 Trial Shows 100% Success Rate for Novel Décolleté Wrinkle Treatment | KRYS Stock News - Stock Titan
Krystal Biotech Inc. Stock Analysis and ForecastFree Stock Movement Tracking - jammulinksnews.com
Krystal Biotech (KRYS) Gets a Buy from Bank of America Securities - The Globe and Mail
0.93%
0.15%
자본화:
|
볼륨(24시간):